Dr. Pramod V. Prabhu, M.D. Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 1401 N Elm St, Henderson, KY 42420 Phone: 270-827-0255 Fax: 270-826-5342 |
Jeffrey R Miller, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1305 N Elm St, Henderson, KY 42420 Phone: 812-485-4415 Fax: 812-471-6650 |
Anthony S Perkins, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1305 N Elm St, Henderson, KY 42420 Phone: 812-471-1591 Fax: 812-471-6650 |
Don E Pruitt, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1305 N Elm St, Henderson, KY 42420 Phone: 812-827-7154 |
Bria Casperson, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1305 N Elm St, Henderson, KY 42420 Phone: 270-827-7700 |
News Archive
Sandata Technologies, Inc., a leading nationwide provider of information technology solutions to the home healthcare and social services communities, and Infocrossing, Inc. today announced the settlement of the patent infringement lawsuit between the two companies.
A modest suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer, researchers from Wake Forest University School of Medicine and other centers reported today at ENDO 2005, the annual meeting of the Endocrine Society, in San Diego.
Centene Corporation today announced its net earnings from continuing operations for the quarter ended September 30, 2009 were $22.7 million, or $0.51 per diluted share, compared to $18.1 million, or $0.41 per diluted share in the third quarter of 2008. The results of operations for our New Jersey health plan, University Health Plans, are classified as discontinued operations.
An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for reducing the often serious side effects of an important class of modern anticancer drugs (tyrosine kinase inhibitors).
› Verified 3 days ago